Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/06/1997 | WO1997040702A1 Oral delivery form having a high absorption efficiency and method for making same |
11/06/1997 | WO1997040701A1 Cross-linked protein gels and methods of making them |
11/06/1997 | WO1997040679A1 Methods for delivering compounds into a cell |
11/06/1997 | WO1997033566A3 Composition and dosage form comprising opioid antagonist |
11/06/1997 | DE19711960A1 Nasal spray |
11/06/1997 | DE19619050A1 Device for controlled release of especially pharmaceuticals |
11/06/1997 | DE19617716A1 In wäßriger Lösung redispergierbare Polymerpulver In aqueous solution redispersible polymer powder |
11/06/1997 | DE19617487A1 Geschmacksverbesserung von Arzneimittelwirkstoffen Improve the taste of active pharmaceutical ingredients |
11/06/1997 | DE19616573A1 Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase Propellant mixtures and aerosols for the micronization of drugs using dense gases |
11/06/1997 | CA2252814A1 Methods of dry powder inhalation |
11/06/1997 | CA2252617A1 Methods for delivering compounds into a cell |
11/05/1997 | EP0804952A1 Process for the preparation of finely devided crystallisation products |
11/05/1997 | EP0804933A2 Storage-stable fibrinogen preparations |
11/05/1997 | EP0804932A2 Contrast media for diagnostic imaging comprising gas filled microspeures |
11/05/1997 | EP0804929A2 Treatment of schistosomiasis |
11/05/1997 | EP0804925A1 Liposome with increased retention volume |
11/05/1997 | EP0804876A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
11/05/1997 | EP0804605A2 Liposome-mediated transfection of central nervous system cells |
11/05/1997 | EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
11/05/1997 | EP0804479A1 Method of treating diabetes mellitus using kgf |
11/05/1997 | EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules |
11/05/1997 | EP0804249A2 Polymeric gene delivery system |
11/05/1997 | EP0804245A1 Collagen preparation for the controlled release of active substances |
11/05/1997 | EP0804243A2 Pharmaceutical products containing thermally-inhibited starches |
11/05/1997 | EP0804241A1 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds |
11/05/1997 | EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
11/05/1997 | EP0804228A1 The use of activated protein c for preparing a pharmaceutical preparation |
11/05/1997 | EP0804225A1 Pharmaceutical compositions comprising a superoxide dismutase |
11/05/1997 | EP0804224A1 A stabilized pharmaceutical formulation comprising a growth hormone and lys-x |
11/05/1997 | EP0804218A1 Product and process for regulating signal transduction pathways |
11/05/1997 | EP0804214A1 Growth differentiation factor-6 |
11/05/1997 | EP0804208A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection |
11/05/1997 | EP0804203A1 Rectal flunisolide compositions for treating inflammatory intestinal disorders |
11/05/1997 | EP0804194A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
11/05/1997 | EP0804191A1 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
11/05/1997 | EP0804181A1 Method and composition for treating mammalian diseases caused by inflammatory response |
11/05/1997 | EP0804179A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
11/05/1997 | EP0804178A1 A gelatine capsule containing selegiline or derivative and paraffin as carrier |
11/05/1997 | EP0804176A1 Transdermal presentation of nitroglycerin for preventing undesired labour |
11/05/1997 | EP0804175A1 Process and device for producing a flat dry-administration form with a preparation containing active medical agents |
11/05/1997 | EP0804174A1 A multicompartment hard capsule with control release properties |
11/05/1997 | EP0804173A1 Controlled release biodegradable microspheres and method of preparation |
11/05/1997 | EP0804172A1 Controlled release potassium dosage form |
11/05/1997 | EP0804171A1 Chewing tablets with an effervescent action |
11/05/1997 | EP0804170A2 Method for making freeze dried drug dosage forms |
11/05/1997 | EP0804169A1 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants |
11/05/1997 | EP0804168A1 Taste masked composition containing a drug/polymer complex |
11/05/1997 | EP0804167A1 Spheronization process using charged resins |
11/05/1997 | EP0804166A1 Controlled release formulation (albuterol) |
11/05/1997 | EP0804165A1 Solid medicament form with active agent distributed in polymer material |
11/05/1997 | EP0804164A2 Method of priming an immune response in a one-day old animal |
11/05/1997 | EP0804163A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
11/05/1997 | EP0804162A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
11/05/1997 | EP0804161A1 Continuous method of grinding pharmaceutical substances |
11/05/1997 | EP0804160A1 Compositions for applying active substances to or through the skin |
11/05/1997 | EP0804159A1 Sphingosomes for enhanced drug delivery |
11/05/1997 | EP0804157A1 Aerosol drug formulations containing vitamin e |
11/05/1997 | EP0804155A1 Composition and method for enhancing transdermal electrotransport agent delivery |
11/05/1997 | EP0804154A1 Transmucosal delivery system |
11/05/1997 | EP0804153A1 Compositions comprising a tissue glue and therapeutic agents |
11/05/1997 | EP0804152A1 Lactulose lozenges |
11/05/1997 | EP0804151A1 Lipophilic and amphiphilic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
11/05/1997 | EP0804150A2 Lotions containing fatty acid derivatives |
11/05/1997 | EP0804146A1 Polyglycerine polyricinoleates |
11/05/1997 | EP0804088A1 Stabilized composition comprising colistin sulfate |
11/05/1997 | EP0676945B1 Encapsulation apparatus and process |
11/05/1997 | EP0493578B1 Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide |
11/05/1997 | CN2266416Y Medical suppository |
11/05/1997 | CN1164187A Percutaneously absorbable patch |
11/05/1997 | CN1164186A Spray-dried microparticles as therapeutic vehicles |
11/05/1997 | CN1164185A Lyophilized preparation providing reversibly thermogelling water-base medicinal composition |
11/05/1997 | CN1163896A Transfection competent molecules |
11/05/1997 | CN1163766A Chinese medicine |
11/05/1997 | CN1163763A Pure Chinese medical liquid for external use |
11/05/1997 | CN1163759A Tea for removing intense heat from throat and moistening throat |
11/05/1997 | CN1163758A Full-natural toilet powder for feet and producing method thereof |
11/05/1997 | CN1163757A Multifunctional gastropathy medicine |
11/05/1997 | CN1163753A Compound antifebrile suppository for children |
11/04/1997 | USRE35653 In vivo delivery of neurotransmitters by implanted, encapsulated cells |
11/04/1997 | US5684178 Compounds for cosmetics or foods |
11/04/1997 | US5684160 3-aminopyrroles, methods for their synthesis and for their pharmaceutical use |
11/04/1997 | US5684121 N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution |
11/04/1997 | US5684050 Stable emulsions of highly fluorinated organic compounds |
11/04/1997 | US5684042 Iodine microbiocides in polymers for mammal skins |
11/04/1997 | US5684040 Compositions in the form of solid solutions |
11/04/1997 | US5683993 Compositions and methods for stabilizing polymers |
11/04/1997 | US5683873 EGS-mediated inactivation of target RNA |
11/04/1997 | US5683740 Covering of protein and phospholipids around cores of lipids for cosmmetics |
11/04/1997 | US5683723 Nanoparticles based on a polyoxyethelene and polyactic acid block copolymer |
11/04/1997 | US5683722 Orally-administered dosage form for animals, preparation method therefor and uses thereof |
11/04/1997 | US5683721 Galenic preparation of therapeutic composition comprising aspirin |
11/04/1997 | US5683720 Liquiflash particles and method of making same |
11/04/1997 | US5683719 Controlled release compositions |
11/04/1997 | US5683718 Enteric coated tablet with raised identification character and method of manufacture |
11/04/1997 | US5683717 Spray coating solid pharmaceuticals |
11/04/1997 | US5683716 Improved oral absorption of poorly soluble drugs |
11/04/1997 | US5683715 Taxane-containing phosphatidylcholine liposomes |
11/04/1997 | US5683713 Transdermal penetration for antioxidants of mercaptoacids, mercaptoesters and amides |
11/04/1997 | US5683712 Transdermal patch for the administration of homeopathic drugs |
11/04/1997 | US5683711 Transdermal drug delivery of estrogen hormones |